JKT · KLBF.JK
PT Kalbe Farma Tbk.
IDR 730+IDR 15 (+2.1%)
PT Kalbe Farma Tbk.’s quoted price sits in the lower half of its reported 52-week range, 45.52% below the high.
Loading market information…
JKT · SIDO.JK · IDR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:13 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Industri Jamu dan Farmasi Sido Muncul Tbk’s quoted price sits in the lower half of its reported 52-week range, 44.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Industri Jamu dan Farmasi Sido Muncul Tbk’s forward annual dividend is IDR 30 per share, paid semi-annual. The forward yield is 9.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
PT Industri Jamu dan Farmasi Sido Muncul Tbk’s next earnings report is currently expected on Feb 8, 2027, with estimated earnings per share of IDR 13. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Industri Jamu dan Farmasi Sido Muncul Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Industri Jamu dan Farmasi Sido Muncul Tbk is an Indonesian enterprise specializing in the production and distribution of herbal remedies, cosmetics, and health-focused food and beverage items. Its operations are divided into three primary segments: Herbal Medicine and Supplements, Food and Beverage, and Pharmacy. The company offers a comprehensive range of both ethical (prescription) and over-the-counter products, addressing a vast array of health concerns such as pain management, immune system support, cardiovascular health, digestive wellness, skin conditions, and various other specific ailments. Beyond its core activities, Sido Muncul also engages in commercial ventures, land transportation, wastewater treatment, plantation management, and printing services. Established in 1940, the company is headquartered in Semarang, Indonesia, and operates as a subsidiary of PT Hotel Candi Baru.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| IDR 900B+10.21% vs estimate |
| Q2 2025 | Jul 31, 2025 | IDR 8+6.67% vs estimate | IDR 1.04T+3.77% vs estimate |
|---|
| Q1 2025 | May 12, 2025 | IDR 8-41.0% vs estimate | IDR 789.11B |
|---|
| Q4 2024 | Mar 6, 2025 | IDR 13+7.55% vs estimate | IDR 1.29T+16.7% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 730+IDR 15 (+2.1%)
PT Kalbe Farma Tbk.’s quoted price sits in the lower half of its reported 52-week range, 45.52% below the high.
IDR 1,100-IDR 60 (-5.17%)
PT SOHO Global Health Tbk.’s quoted price sits in the lower half of its reported 52-week range, 72.57% below the high.
IDR 2,410-IDR 80 (-3.21%)
PT Tempo Scan Pacific Tbk’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
IDR 2,370-IDR 50 (-2.07%)
PT Enseval Putera Megatrading Tbk.’s quoted price sits in the lower half of its reported 52-week range, 18.28% below the high.
IDR 191+IDR 1 (+0.53%)
Medela Potentia Tbk.’s quoted price sits in the lower half of its reported 52-week range, 36.33% below the high.
IDR 338-IDR 20 (-5.59%)
PT Kimia Farma (Persero) Tbk’s quoted price sits in the lower half of its reported 52-week range, 56.94% below the high.
IDR 1,570IDR 0 (0.0%)
PT Darya-Varia Laboratoria Tbk’s quoted price sits in the upper half of its reported 52-week range, 7.37% below the high.
IDR 3,610IDR 0 (0.0%)
PT Merck Tbk’s quoted price sits in the lower half of its reported 52-week range, 19.78% below the high.
